Product Description
Mechanisms of Action: Immunosuppressive
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Percutaneous
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Australia | Colombia
Approved Indications: None
Known Adverse Events: None
Company: PaceMate
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 4: Coronary Artery Disease|Myocardial Ischemia|Angina, Stable|Acute Coronary Syndrome|Myocardial Infarction|Angina Pectoris|Angina, Unstable|Coronary Stenosis|Coronary Restenosis|Coronary Disease|ST Elevation Myocardial Infarction|Inflammation|Thrombosis
Phase 3: Arteriosclerosis|Coronary Artery Disease|Myocardial Ischemia|Coronary Occlusion|Coronary Stenosis
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| ONYSOVER | N/A |
Recruiting |
Coronary Artery Disease|Myocardial Ischemia |
2025-12-31 |
|
| ZEVS-HBR | N/A |
Unknown status |
Coronary Artery Disease |
2024-02-28 |
|
| DEBORA | N/A |
Terminated |
Myocardial Ischemia|Coronary Artery Disease |
2021-09-29 |
|
| CNUH-2017-319 | N/A |
Completed |
Coronary Artery Disease|Myocardial Ischemia |
2021-03-18 |
|
| MDT16058RES004 | N/A |
Active, not recruiting |
Coronary Artery Disease|Arteriosclerosis|Myocardial Ischemia |
2021-02-24 |
|
| MDT16061RES005 | N/A |
Active, not recruiting |
Myocardial Ischemia|Coronary Artery Disease|Arteriosclerosis |
2021-02-12 |
|
| the DK Culotte-I Study | N/A |
Completed |
Myocardial Ischemia|Coronary Artery Disease |
2020-12-01 |
|
| SHEAR-STENT | N/A |
Completed |
Coronary Artery Disease |
2020-12-01 |
|
| Bifurcation Cohort | N/A |
Completed |
Coronary Artery Disease |
2020-11-04 |
|
| Onyx ONE Clear | N/A |
Completed |
Coronary Artery Disease |
2020-03-10 |
|
| CL-VP-02 | N/A |
Completed |
Coronary Disease |
2020-01-10 |
|
| ONYX PAS | N/A |
Completed |
Coronary Artery Disease |
2018-10-20 |
|
| Onyx ONE | N/A |
Completed |
Coronary Artery Disease |
2018-09-27 |
|
| MDT16003RES001 | N/A |
Completed |
Myocardial Ischemia|Arteriosclerosis|Coronary Artery Disease |
2018-07-31 |
|
| APPOSITION-AMI II | N/A |
Unknown status |
Coronary Artery Disease|Myocardial Ischemia|Arteriosclerosis|Arterial Occlusive Diseases |
2018-06-01 |
|
| HOST-ONYX | N/A |
Unknown status |
Coronary Artery Disease|Myocardial Infarction|Angina Pectoris|Myocardial Ischemia|Acute Coronary Syndrome |
2018-05-01 |
|
| CHOICE | N/A |
Terminated |
Myocardial Ischemia|Coronary Artery Disease |
2017-12-05 |
|
| RESOLUTE-DM | N/A |
Completed |
Myocardial Ischemia|Coronary Artery Disease |
2015-11-01 |
|
| CHINA RESOLUTE INTEGRITY STUDY | P3 |
Completed |
Coronary Artery Disease|Myocardial Ischemia|Arteriosclerosis |
2015-08-01 |
|
| PERFECT | P4 |
Completed |
Myocardial Ischemia|Coronary Artery Disease |
2015-06-01 |
|
| CROSS | P4 |
Completed |
Coronary Artery Disease|Myocardial Ischemia |
2015-01-01 |
|
| ZES for STEMI | P4 |
Unknown status |
ST Elevation Myocardial Infarction|Myocardial Ischemia|Coronary Artery Disease |
2013-12-01 |
|
| CTO | P4 |
Unknown status |
Coronary Artery Disease|Myocardial Ischemia |
2013-10-01 |
|
| MUW-0001 | P4 |
Completed |
Thrombosis|Inflammation |
2013-08-01 |
|
| PROTECT-CA | P4 |
Completed |
Myocardial Ischemia|Myocardial Infarction|Coronary Artery Disease |
2013-03-01 |